全文获取类型
收费全文 | 23948篇 |
免费 | 1608篇 |
国内免费 | 138篇 |
专业分类
耳鼻咽喉 | 312篇 |
儿科学 | 541篇 |
妇产科学 | 412篇 |
基础医学 | 3205篇 |
口腔科学 | 595篇 |
临床医学 | 2152篇 |
内科学 | 4687篇 |
皮肤病学 | 316篇 |
神经病学 | 2750篇 |
特种医学 | 916篇 |
外国民族医学 | 1篇 |
外科学 | 3066篇 |
综合类 | 269篇 |
一般理论 | 14篇 |
预防医学 | 2296篇 |
眼科学 | 796篇 |
药学 | 1887篇 |
中国医学 | 58篇 |
肿瘤学 | 1421篇 |
出版年
2023年 | 107篇 |
2022年 | 188篇 |
2021年 | 474篇 |
2020年 | 272篇 |
2019年 | 407篇 |
2018年 | 521篇 |
2017年 | 402篇 |
2016年 | 408篇 |
2015年 | 493篇 |
2014年 | 742篇 |
2013年 | 1068篇 |
2012年 | 1577篇 |
2011年 | 1642篇 |
2010年 | 891篇 |
2009年 | 750篇 |
2008年 | 1507篇 |
2007年 | 1650篇 |
2006年 | 1616篇 |
2005年 | 1609篇 |
2004年 | 1572篇 |
2003年 | 1444篇 |
2002年 | 1408篇 |
2001年 | 264篇 |
2000年 | 234篇 |
1999年 | 273篇 |
1998年 | 304篇 |
1997年 | 273篇 |
1996年 | 221篇 |
1995年 | 246篇 |
1994年 | 157篇 |
1993年 | 191篇 |
1992年 | 169篇 |
1991年 | 146篇 |
1990年 | 145篇 |
1989年 | 142篇 |
1988年 | 117篇 |
1987年 | 134篇 |
1986年 | 125篇 |
1985年 | 143篇 |
1984年 | 142篇 |
1983年 | 134篇 |
1982年 | 181篇 |
1981年 | 195篇 |
1980年 | 163篇 |
1979年 | 101篇 |
1978年 | 102篇 |
1977年 | 122篇 |
1976年 | 104篇 |
1975年 | 65篇 |
1974年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
2.
3.
Jamaal L. Benjamin MD PhD Rebecca Dennis DO Stacy White Jr MD David Munson MD Sudha A. Anupindi MD Maciej Piskunowicz MD Kassa Darge MD PhD Ami Gokli MD Misun Hwang MD 《Journal of ultrasound in medicine》2020,39(5):1031-1036
Bowel diseases of prematurity, including necrotizing enterocolitis, are dreaded ailments of neonates. Early diagnosis is difficult, with clinical and radiographic findings often inconclusive. We present a novel use of contrast-enhanced ultrasound in detection of pediatric bowel disease. Early identification of compromised blood flow or an at-risk bowel can be quantitatively detected and monitored. This ability has implications for guidance of emerging therapies, allowing targeting of inflammation. These findings represent an advancement in detection of bowel disease in neonates. 相似文献
4.
5.
Shylo R. Johnson Dennis Slate Kathleen M. Nelson Amy J. Davis Samual A. Mills John T. Forbes Kurt C. VerCauteren Amy T. Gilbert Richard B. Chipman 《Viruses》2021,13(2)
Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor) and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to meet the rabies management goal of raccoon RV elimination. This study describes the continuation of a 2011 trial in West Virginia. Our objective was to evaluate raccoon and skunk response to ORV occurring in West Virginia for an additional two years (2012–2013) at 75 baits/km2 followed by three years (2014–2016) of evaluation at 300 baits/km2. We measured the change in rabies virus-neutralizing antibody (RVNA) seroprevalence in targeted wildlife populations by comparing levels pre- and post-ORV during each year of study. The increase in bait density from 75/km2 to 300/km2 corresponded to an increase in average post-ORV seroprevalence for raccoon and skunk populations. Raccoon population RVNA levels increased from 53% (300/565, 95% CI: 50–57%) to 82.0% (596/727, 95% CI: 79–85%) during this study, and skunk population RVNA levels increased from 11% (8/72, 95% CI: 6–20%) to 39% (51/130, 95% CI: 31–48%). The RVNA seroprevalence pre-ORV demonstrated an increasing trend across study years for both bait densities and species, indicating that multiple years of ORV may be necessary to achieve and maintain RVNA seroprevalence in target wildlife populations for the control and elimination of raccoon RV in the eastern USA. 相似文献
6.
7.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献
8.
9.
10.
José Roberto Jurado Jorge Hernán Santos Nieto Jairo Ospina Gaitán Constanza Garzón Bonilla Ricardo Villarreal David Acevedo Laura Cabrera Luis Felipe Cabrera Mauricio Pedraza 《Arab Journal Of Gastroenterology》2021,22(2):170-173
Background and study aimsThe COVID-19 outbreak has reorganized surgical team conditions regarding endoscopy. The number of interventions has been reduced, the number of healthcare professionals must be limited, and both the patients and physicians are more protected than ever.Patients and MethodsIn the highest peak of contagion in Colombia, endoscopy, colonoscopy, and esophagogastroduodenoscopy were performed using a low-cost disposable device. A total of 1388 procedures were performed. Every patient was assessed for symptoms via a telephone call, at the health center, and after the procedure, following specific attention routes.ResultsAfter procedure follow-up, no positive cases of COVID-19 were noted.ConclusionThe methodology reduced the risk of infection during the COVID-19 pandemic. 相似文献